Clinical trial
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian…
NCT00011986 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00011986 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer |
| Official title | A Phase III Randomized Trial Of Paclitaxel And Carboplatin Versus Triplet Or Sequential Doublet Combinations In Patients With Epithelial Ovarian Or Primary Peritoneal Carcinoma |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | SWOG Cancer Research Network Medical Research Council National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Primary Peritoneal Carcinoma, Stage III Ovarian Cancer, Stage IV Ovarian Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Paclitaxel, Carboplatin, Gemcitabine Hydrochloride, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan Hydrochloride, Therapeutic Conventional Surgery |
| Enrollment | 4,312 |
| Start date | Jan 1, 2001 |
| Primary completion | Mar 1, 2010 |
| Completion | Jan 28, 2013 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: